A pivotal constraint hindering the efficacy of cancer vaccines lies in their inefficient in vivo delivery and associated side effects, where administered vaccines frequently fail to reach their intended targets.[26] In our study, we utilized bezafibrate to regulate PD‐L1 nb expression in tumor cells, significantly reducing PD‐L1 expression in vitro. Here, CD274 is linked to cancer.